PDCD1 and hepatocellular carcinoma: Studies have shown that HCC patients show high expression of PD-1 in CD8+ T-cells and display increased circulating and tumor-infiltrating PD-1+/CD8+ T-cells, which can be used for disease prediction and to assess postoperative recurrence (Shi et al., 2011).